Senescence in Pulmonary Fibrosis: Between Aging and Exposure

Frontiers in Medicine

article

Alessandro Venosa¹ 

[1] Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, United States

关键词: senescence;    lung fibrosis;    epithelial cells;    inflamm-aging;    immune-senescence;    aging;    mesenchymal senescence;   

DOI  :  10.3389/fmed.2020.606462

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

To date, chronic pulmonary pathologies represent the third leading cause of death in the elderly population. Evidence-based projections suggest that >65 (years old) individuals will account for approximately a quarter of the world population before the turn of the century. Genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication, are described as the nine “hallmarks” that govern cellular fitness. Any deviation from the normal pattern initiates a complex cascade of events culminating to a disease state. This blueprint, originally employed to describe aberrant changes in cancer cells, can be also used to describe aging and fibrosis. Pulmonary fibrosis (PF) is the result of a progressive decline in injury resolution processes stemming from endogenous (physiological decline or somatic mutations) or exogenous stress. Environmental, dietary or occupational exposure accelerates the pathogenesis of a senescent phenotype based on (1) window of exposure; (2) dose, duration, recurrence; and (3) cells type being targeted. As the lung ages, the threshold to generate an irreversibly senescent phenotype is lowered. However, we do not have sufficient knowledge to make accurate predictions. In this review, we provide an assessment of the literature that interrogates lung epithelial, mesenchymal, and immune senescence at the intersection of aging, environmental exposure and pulmonary fibrosis.

【 授权许可】

CC BY